• New Nordic Healthbrands net sales rose 14.5% to SEK 163.8 million in Q2; net profit more than doubled to SEK 7.3 million.
• Operating profit climbed to SEK 9 million; gross margin fell 1.3 percentage points to 63.5%.
• First-half net sales increased 3.3% to SEK 296.2 million; net profit slipped to SEK 4.4 million.
• CEO cited record revenue on strong distributor performance in Asia, with solid growth in the Nordics and the US.
• Gross margin eased due to a higher share of distributor sales; initiatives launched to lift direct-to-consumer sales over time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. New Nordic Healthbrands AB published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.